Anemia is a condition characterized by a deficiency in red blood cells or hemoglobin, which affects the body's ability to deliver oxygen to its tissues. This common healthcare issue can have several underlying causes, such as iron deficiency, vitamin B12 or folate deficiencies, chronic diseases like kidney failure or rheumatoid arthritis, and even genetic disorders. The symptoms of anemia can vary depending on its type and severity but often include fatigue, shortness of breath, dizziness, pale skin coloration, rapid heartbeat, or irregular heart rhythm. To diagnose anemia accurately and determine its cause precisely, doctors may perform blood tests measuring red blood cell count and hemoglobin levels alongside other diagnostic investigations. Treatment for anemia depends on the root cause but typically involves dietary changes with increased intake of iron-rich foods (such as leafy greens and lean meats), oral supplements like iron tablets or injections when necessary, and addressing any underlying conditions that contribute to this health concern.
1.
New policy review highlights the importance of health-related quality of life in advanced cancer
2.
New protocols, according to a study, allow many patients to safely return home one day after lung cancer surgery.
3.
Study identifies new target for obesity-related breast cancer
4.
Novel Agent Effective for Cancer Wasting Disorder
5.
The response of bipolar patients to lithium may be predicted by ancestry.
1.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
2.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
3.
Integrated Updates in Oncology for Specialists
4.
Pediatric Advances in Mapping Hematopoietic Development During Childhood
5.
The Importance of Balanced Potassium Levels in Maintaining Good Health
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
2.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation